Literature DB >> 27039307

Interferon-Gamma Release Assays for the Diagnosis of Tuberculosis: A Systematic Review and Meta-analysis.

Peng Lu1,2, Xiu Chen3, Li-Mei Zhu2, Hai-Tao Yang4,5.   

Abstract

BACKGROUND AND
OBJECTIVE: We conducted a systematic review and meta-analysis to compare the accuracy of the interferon-gamma release assays (IGRAs) and the tuberculin skin test (TST) for the diagnosis of Mycobacterium tuberculosis infection.
METHODS: We systematically searched PubMed, Embase, Cochrane library, and Web of Science databases for relevant published studies in recent decades and calculated pooled estimated sensitivities, specificities, DOR, and SROC curve of the QFT-IT, T-SPOT and TST. Random-effects models were used to assess estimates from studies with significant heterogeneity. Moreover, area under the curve was used to evaluate the accuracy of the tests.
RESULTS: Overall, 9 studies for QFT-IT, 12 studies for T-SPOT, and 16 studies for TST involving 3586 participants were included in this analysis. We found that sensitivities of the QFT-IT, T-SPOT, and TST were respectively 0.842 (95 % CI 0.811-0.870), 0.840 (95 % CI 0.814-0.864), and 0.665 (CI 0.635-0.693); specificities were respectively 0.745 (95 % CI 0.715-0.775), 0.658 (95 % CI 0.621-0.693), and 0.633 (CI 0.605-0.661); positive likelihood ratios were respectively 3.652 (95 % CI 2.180-6.117), 2.196 (95 % CI 1.727-2.794), and 1.825 (95 % CI 1.351-2.464); negative likelihood ratios were respectively 0.212 (95 % CI 0.109-0.414), 0.246 (95 % CI 0.161-0.377), and 0.556 (95 % CI 0.385-0.804); the SROC curves were 19.205, 10.397, and 3.810.
CONCLUSIONS: The two IGRAs showed better performance than TST for the diagnosis of the tuberculosis. However, neither of them showed stability in the diagnosis of TB.

Entities:  

Keywords:  Diagnosis; Interferon-gamma release assays; Specificity; Tuberculin skin test; Tuberculosis

Mesh:

Year:  2016        PMID: 27039307     DOI: 10.1007/s00408-016-9872-5

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  35 in total

1.  Interferon gamma release assay in diagnosis of pediatric tuberculosis: a meta-analysis.

Authors:  Lin Sun; Jing Xiao; Qing Miao; Wei-xing Feng; Xi-rong Wu; Qing-qin Yin; Wei-wei Jiao; Chen Shen; Fang Liu; Dan Shen; A-dong Shen
Journal:  FEMS Immunol Med Microbiol       Date:  2011-11

2.  Comparison of tuberculin skin testing and T-SPOT.TB for diagnosis of latent and active tuberculosis.

Authors:  Hulya Simsek; Sibel Alpar; Nazire Ucar; Funda Aksu; Ismail Ceyhan; Aysegul Gözalan; Salih Cesur; Mustafa Ertek
Journal:  Jpn J Infect Dis       Date:  2010-03       Impact factor: 1.362

3.  Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count.

Authors:  Keertan Dheda; Ajit Lalvani; Robert F Miller; Geoff Scott; Helen Booth; Margaret A Johnson; Alimuddin Zumla; Graham Aw Rook
Journal:  AIDS       Date:  2005-11-18       Impact factor: 4.177

4.  Clinical utility of QuantiFERON-TB GOLD In-Tube and tuberculin skin test in patients with tuberculous pleural effusions.

Authors:  Jae Ho Chung; Chang Hoon Han; Chong Ju Kim; Sun Min Lee
Journal:  Diagn Microbiol Infect Dis       Date:  2011-08-31       Impact factor: 2.803

5.  The sensitivity of T-SPOT.TB assay in diagnosis of pediatric tuberculosis.

Authors:  Xinfeng Wang; Yanhua Wu; Maoshui Wang; Yunshan Wang
Journal:  Fetal Pediatr Pathol       Date:  2014-01-28       Impact factor: 0.958

6.  Diagnostic usefulness of a T-cell based assay for extrapulmonary tuberculosis.

Authors:  Sung-Han Kim; Su-Jin Choi; Hong-Bin Kim; Nam-Joong Kim; Myoung-Don Oh; Kang-Won Choe
Journal:  Arch Intern Med       Date:  2007-11-12

7.  Diagnostic usefulness of a T-cell-based assay for extrapulmonary tuberculosis in immunocompromised patients.

Authors:  Sung-Han Kim; Kyoung-Ho Song; Su-Jin Choi; Hong-Bin Kim; Nam-Joong Kim; Myoung-don Oh; Kang-Won Choe
Journal:  Am J Med       Date:  2009-02       Impact factor: 4.965

8.  Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis.

Authors:  A K Detjen; T Keil; S Roll; B Hauer; H Mauch; U Wahn; K Magdorf
Journal:  Clin Infect Dis       Date:  2007-06-15       Impact factor: 9.079

9.  Interferon-gamma release assay performance in pulmonary and extrapulmonary tuberculosis.

Authors:  Yun Feng; Ni Diao; Lingyun Shao; Jing Wu; Shu Zhang; Jialin Jin; Feifei Wang; Xinhua Weng; Ying Zhang; Wenhong Zhang
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

10.  Diagnostic performance of interferon-gamma releasing assay in HIV-infected patients in China.

Authors:  Yanhua Yu; Xiuying Zhao; Wen Wang; Hao Wu; Ming Chen; Wenhao Hua; Huizhu Wang; Ting Wei; Yanmei Jiao; Guizhen Sun; Wei Li
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

View more
  17 in total

1.  Correlation between the tuberculin skin test and T-SPOT.TB in patients with suspected tuberculosis infection: A pilot study.

Authors:  Jing Yang; Weiliang Kong; Ning Xv; Xiaoping Huang; Xueqing Chen
Journal:  Exp Ther Med       Date:  2019-07-18       Impact factor: 2.447

2.  Diagnostic accuracy of interferon-gamma release assays for diagnosis of smear-negative pulmonary tuberculosis: a systematic review and meta-analysis.

Authors:  Tananchai Petnak; Dararat Eksombatchai; Supavit Chesdachai; Ploypin Lertjitbanjong; Pahnwat Taweesedt; Angsupat Pornchai; Charat Thongprayoon; Larry J Prokop; Zhen Wang
Journal:  BMC Pulm Med       Date:  2022-06-06       Impact factor: 3.320

3.  Screening for TB in Hospitalised Patients with Inflammatory Bowel Disease before Anti-TNF Therapy: Is QuantiFERON® Gold Testing Useful?

Authors:  Jessica Lovatt; Deborah Gascoyne-Binzi; Thomas Hussey; Maya Garside; Fiona McGill; Christian P Selinger
Journal:  J Clin Med       Date:  2021-04-21       Impact factor: 4.241

4.  Use of the QuantiFERON-TB Gold In-Tube Test in the Diagnosis and Monitoring of Treatment Efficacy in Active Pulmonary Tuberculosis.

Authors:  Ping-Chin Chang; Pin-Hui Wang; Kow-Tong Chen
Journal:  Int J Environ Res Public Health       Date:  2017-02-27       Impact factor: 3.390

5.  Prospective Comparison of QFT-GIT and T-SPOT.TB Assays for Diagnosis of Active Tuberculosis.

Authors:  Fengjiao Du; Li Xie; Yonghong Zhang; Fei Gao; Huibin Zhang; Wei Chen; Bingqi Sun; Wei Sha; Yong Fang; Hongyan Jia; Aiying Xing; Boping Du; Li Zheng; Mengqiu Gao; Zongde Zhang
Journal:  Sci Rep       Date:  2018-04-12       Impact factor: 4.379

6.  Diagnostic Value of Interferon-Gamma Release Assays Combined with Multiple Indicators for Tuberculous Peritonitis.

Authors:  Xidong He; Yuanxue Gao; Qi Liu; Zhifang Zhao; Wanhang Deng; Hong Yang
Journal:  Gastroenterol Res Pract       Date:  2020-03-20       Impact factor: 2.260

7.  A Systematic Review on Novel Mycobacterium tuberculosis Antigens and Their Discriminatory Potential for the Diagnosis of Latent and Active Tuberculosis.

Authors:  Noëmi R Meier; Marc Jacobsen; Tom H M Ottenhoff; Nicole Ritz
Journal:  Front Immunol       Date:  2018-11-09       Impact factor: 7.561

8.  Influence of Seasonality and Circulating Cytokines on Serial QuantiFERON Discordances.

Authors:  Marsha L Griffin; Saroochi Agarwal; Melissa Zhu Murphy; Larry D Teeter; Edward A Graviss
Journal:  Tuberc Res Treat       Date:  2018-03-12

9.  Predictors for false-negative QuantiFERON-TB Gold assay results in patients with extrapulmonary tuberculosis.

Authors:  Youn Jeong Kim; Ji Young Kang; Sang Il Kim; Mee Soo Chang; Yang Ree Kim; Yeon Joon Park
Journal:  BMC Infect Dis       Date:  2018-09-10       Impact factor: 3.090

10.  QuantiFERON-TB Gold In-Tube test in active tuberculosis patients and healthy adults.

Authors:  Benjawan Phetsuksiri; Sopa Srisungngam; Janisara Rudeeaneksin; Supranee Boonchu; Wiphat Klayut; Ronnayuth Norrarat; Somchai Sangkitporn; Yuthichai Kasetjaroen
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2018-10-22       Impact factor: 1.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.